$1.735
-0.776 (-44.75%)Zum Schluss
Kursprognosen
In der App öffnen, um Prognosen mit längerem Horizont freizuschalten.
BCAB-Prognose durch Analyse ähnlicher Charts
Alphio's BCAB stock price prediction model matches the current Bioatla Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $1.74 (+0.52%). The 1-week path is $1.77 (+2.17%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
Soll ich Bioatla Inc-Aktien kaufen?
BioAtla Inc is not a good buy right now due to its significant financial losses and poor stock performance. The current price is $1.74, which is a staggering 96.60% lower than its 1-year high of $71.50. Furthermore, the company has reported a negative net income of -$6,344,000 in Q1 2026, and a forward P/E ratio of 0 indicates uncertainty about future earnings. The recent hedge fund selling activity has increased by 760.39%, signaling a lack of confidence among institutional investors, which adds to the risk of holding this stock.
BCAB schloss am Friday bei $1.74, nachdem der Kurs -44.75% fallen
Bioatla Inc (BCAB) last closed at $1.735, losing -44.75%. These facts feed the 1-day and 1-week BCAB price prediction above.
Prognose-Treiber
Die Prognose-Treiber von Bioatla Inc (BCAB) kombinieren ähnliche Chartmuster, Saisonalität und gleitende Durchschnitte.
Similar patterns
Bearish
Seasonality
Bearish
SMA 20
Bearish
SMA 200
Bearish
Ähnliche Chartmuster
Aktien, deren jüngster Kursverlauf BCAB am ähnlichsten ist, sortiert nach Ähnlichkeit.
Saisonalitätsanalyse für BCAB
Historically the probability of a positive November return for BCAB is 48.72%. December offers the highest probability of a positive month at 48.84%, while June is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
10-Jahres-Kursprojektionen für BCAB
| Monat | Tiefstkurs | Ø-Kurs | Höchstkurs | Potenzieller ROI |
|---|---|---|---|---|
| Nov 2026 | $0.40 | $0.43 | $0.51 | -75.50% |
| Dec 2026 | $0.32 | $0.39 | $0.43 | -77.60% |
Für 2026 wird für Bioatla Inc (BCAB) eine Spanne von $0.32 bis $0.51 projiziert.
Monatsprognose 2026 für Bioatla Inc
Im Nov 2026 wird für Bioatla Inc ein Durchschnitt von $0.43 erwartet, mit einem Tief von $0.40 und einem Hoch von $0.51.
Im Dec 2026 wird für Bioatla Inc ein Durchschnitt von $0.39 erwartet, mit einem Tief von $0.32 und einem Hoch von $0.43.
Ähnliche Artikel
- Equal-Weight vs Cap-Weighted S&P 500: RSP vs SPY After October's Rotation and Nvidia's CEO ShockEqual weight vs cap weighted S&P 500: how RSP and SPY differ, why October 2026's rotation was the widest since 2009, and how to blend both after Nvidia's shock.
- Money Market Funds vs High-Yield Savings vs T-Bills: Where to Park Cash as the Fed HikesMoney market funds, high-yield savings or T-bills? Compare November 2026 yields, taxes, FDIC rules and liquidity as the Fed hikes, and build a smart cash plan.
- Homebuilder Stocks With Mortgage Rates Above 7%: An Investor's Guide for Late 2026Homebuilder stocks face 7% mortgage rates and a 16-year low in home sales. See what D.R. Horton, Lennar and Pulte earnings show and how to invest in 2026.
Diese Seite dient nur der Recherche und ist keine Anlageberatung. Modelle können falsch liegen. Vergangene Wertentwicklung ist kein Indikator für die Zukunft.